| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 127 |
| 1 | INFLIXIMAB | 80 |
| 2 | PREDNISONE | 64 |
| 3 | METHOTREXATE SODIUM | 57 |
| 4 | VEDOLIZUMAB | 53 |
| 5 | METHOTREXATE | 43 |
| 6 | AZATHIOPRINE | 38 |
| 7 | FENTANYL | 32 |
| 8 | MESALAMINE | 31 |
| 9 | ADALIMUMAB-ADAZ | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND CHLOROXYLENOL | 1 | 0.0222 |
| 1 | HOMOSALATE, OCTISALATE, AVOBENZONE, AND DIMETHICONE | 1 | 0.0217 |
| 2 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 3 | SODIUM THIOSULFATE | 3 | 0.0054 |
| 4 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 5 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 20 | 0.0024 |
| 7 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 6 | 0.0015 |
| 9 | PURIXAN | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 110 |
| 1 | Corticosteroid [EPC] | 102 |
| 2 | Integrin Receptor Antagonist [EPC] | 53 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 4 | Purine Antimetabolite [EPC] | 38 |
| 5 | Opioid Agonist [EPC] | 34 |
| 6 | Retinoid [EPC] | 27 |
| 7 | Aminosalicylate [EPC] | 26 |
| 8 | Vitamin C [EPC] | 23 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 53 | 0.0006 |
| 1 | Purine Antimetabolite [EPC] | 38 | 0.0004 |
| 2 | GLP-2 Analog [EPC] | 5 | 0.0004 |
| 3 | Vitamin K [EPC] | 3 | 0.0003 |
| 4 | Glycopeptide Antibacterial [EPC] | 20 | 0.0003 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Aminosalicylate [EPC] | 26 | 0.0003 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 8 | Parenteral Iron Replacement [EPC] | 3 | 0.0002 |
| 9 | Interleukin-12 Antagonist [EPC] | 14 | 0.0001 |